Meditect is a French start-up company whose mission is to fight against the sale of falsified medicines and the diversion of batches, as well as to strengthen the legal distribution of medicines in developing countries. A real public health issue, trafficking in fake medicines kills at least 100,000 people a year on the African continent and represents up to 7 out of 10 medicines in some countries. Meditect offers an innovative mobile solution that combines blockchain and artificial intelligence to allow pharmacists and patients to scan their medicines to ensure their authenticity.

Main sectors: Healthcare & Biotechnologies; Supply Chains & Logistics

Main applications: Supply Chain Management/Trade;
Disintermediation and decentralized networks;
Data Marketplace/Data monetization

Established in: 2017

URL: https://www.meditect.com/

Organisation: SAS Meditect

Organisation type: Companies (for-profit) – Startup

Founders: Arnaud Pourredon, CEO & Co-founder; Romain Renard, CFO & Co-founder; Sacha Servan-Schreiber, Co-founder

Partners: N/A

Country: France

City: Bordeaux

Stage of project: Pilot

Geographical reach: International

DLT / Blockchain: Private – Permissionate BTC

Other technologies: AI / Machine Learning / Deep Learning

Whitepaper: N/A

Github: https://github.com/Meditect/blockchain_go;   https://github.com/Meditect

Twitter: https://twitter.com/meditect

This project is part of the #DLT4Good Scanning. ‘#DLT4Good: Co-creating a European Ecosystem of Distributed Ledger Technologies for Social and Public Good’ is a forward-looking science for policy project supported by the European Parliament, and coordinated by the Joint Research Centre (JRC) in cooperation with the Directorate-General for Communications Networks, Content & Technology (DG CONNECT). Learn more about #DLT4Good.